Stoyanova A - Search Results

1

The combination of pleconaril, rupintrivir, and remdesivir efficiently inhibits enterovirus infections in vitro, delaying the development of drug-resistant virus variants.

Ianevski A, Frøysa IT, Lysvand H, Calitz C, Smura T, Schjelderup Nilsen HJ, Høyer E, Afset JE, Sridhar A, Wolthers KC, Zusinaite E, Tenson T, Kurg R, Oksenych V, Galabov AS, Stoyanova A, Bjørås M, Kainov DE. Ianevski A, et al. Among authors: stoyanova a. Antiviral Res. 2024 Apr;224:105842. doi: 10.1016/j.antiviral.2024.105842. Epub 2024 Feb 26. Antiviral Res. 2024. PMID: 38417531 Free article.

2

Effect of consecutive alternating administration (CAA) of a triple anti-enteroviral combination on Coxsackievirus B1 neuroinfection in mice.

Stoyanova A, Nikolova I, Galabov AS. Stoyanova A, et al. Antiviral Res. 2015 Sep;121:138-44. doi: 10.1016/j.antiviral.2015.07.004. Epub 2015 Jul 18. Antiviral Res. 2015. PMID: 26196747

3

Three-dimensional analysis of combination effect of ellagitannins and acyclovir on herpes simplex virus types 1 and 2.

Vilhelmova N, Jacquet R, Quideau S, Stoyanova A, Galabov AS. Vilhelmova N, et al. Among authors: stoyanova a. Antiviral Res. 2011 Feb;89(2):174-81. doi: 10.1016/j.antiviral.2010.11.014. Epub 2010 Dec 4. Antiviral Res. 2011. PMID: 21134403

4

Effect of Consecutive Alternating Administration of a Triple Combination of Anti-Enteroviral Compounds in Mice Infected with Coxsackievirus B3.

Stoyanova A, Galabov AS. Stoyanova A, et al. Pathog Dis. 2020 Nov 23;78(9):ftaa065. doi: 10.1093/femspd/ftaa065. Pathog Dis. 2020. PMID: 33090201

5

Consecutive alternating administration as an effective anti-coxsackievirus B3 in vivo treatment scheme.

Stoyanova A, Galabov AS. Stoyanova A, et al. Arch Virol. 2021 Jul;166(7):1869-1875. doi: 10.1007/s00705-021-05057-3. Epub 2021 Apr 20. Arch Virol. 2021. PMID: 33877422

6

Anti-enteroviral triple combination of viral replication inhibitors: activity against coxsackievirus B1 neuroinfection in mice.

Stoyanova A, Nikolova I, Pürstinger G, Dobrikov G, Dimitrov V, Philipov S, Galabov AS. Stoyanova A, et al. Antivir Chem Chemother. 2015 Dec;24(5-6):136-147. doi: 10.1177/2040206616671571. Epub 2016 Nov 4. Antivir Chem Chemother. 2015. PMID: 27815331 Free PMC article.

7

Genome analysis of coxsackievirus B1 isolates during the consecutive alternating administration course of triple antiviral combination in newborn mice.

Grozdanov P, Joffret ML, Stoyanova A, Polston P, Achouri E, Nikolova I, Delpeyroux F, Galabov AS. Grozdanov P, et al. Among authors: stoyanova a. Antivir Chem Chemother. 2020 Jan-Dec;28:2040206620906061. doi: 10.1177/2040206620906061. Antivir Chem Chemother. 2020. PMID: 32041425 Free PMC article.

8

Effects of double combinations of enterovirus replication inhibitors against Coxsackie B viruses.

Stoyanova A, Galabov AS. Stoyanova A, et al. Acta Virol. 2021;65(4):411-419. doi: 10.4149/av_2021_410. Acta Virol. 2021. PMID: 34978843

9

Antiviral Combination Approach as a Perspective to Combat Enterovirus Infections.

Galabov AS, Nikolova I, Vassileva-Pencheva R, Stoyanova A. Galabov AS, et al. Among authors: stoyanova a. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2015;36(2):91-9. doi: 10.1515/prilozi-2015-0057. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2015. PMID: 27442375 Free article. Review.

10

Synthesis and anti-enterovirus activity of new analogues of MDL-860.

Dobrikov GM, Slavchev I, Nikolova I, Stoyanova A, Nikolova N, Mukova L, Nikolova R, Shivachev B, Galabov AS. Dobrikov GM, et al. Among authors: stoyanova a. Bioorg Med Chem Lett. 2017 Oct 1;27(19):4540-4543. doi: 10.1016/j.bmcl.2017.08.056. Epub 2017 Aug 30. Bioorg Med Chem Lett. 2017. PMID: 28870395

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

100 results

Search Page